Skip to main content (Press Enter).
Skip auxiliary navigation (Press Enter).
Skip main navigation (Press Enter).
on this day
between these dates
COVID 19 Vaccine
Open Member Community
AKI, Billing & Reimbursement
Join a Community
Join A Committee
Renal Services Exchange
Renew Your Membership
Mircera® in Dialysis – a US Experience
Jun 30, 2021 from 01:00 PM to 02:00 PM (ET)
Since December 2014, Mircera® (methoxy polyethylene glycol-epoetin beta) injection, for intravenous or subcutaneous use, has been available in the United States. Initially, available exclusively via FKC dialysis clinics, as of late 2017, Mircera® was introduced by other dialysis providers as well. Expanded use of Mircera® in recent years has allowed many US dialysis providers to gain valuable first-hand experience with this long-acting ESA, some of which has been described and shared in recent publications. Presenters will share general information, key findings, and published conclusions based on the Mircera® US experience.
Download to Your Calendar
Skip Navigation Links
Copyright 2021 Connect. All rights reserved.
19 Mantua Road
Mount Royal, NJ 08061 USA
2021 Renal Healthcare Association. All Rights Reserved.
Powered by Higher Logic